What is Apretude (cabotegravir) used for?
Apretude is the brand name for cabotegravir, an antiretroviral medicine used for HIV prevention. It’s used as pre-exposure prophylaxis (PrEP) for people who are at risk of acquiring HIV, to lower the chance of infection with HIV.
How is Apretude taken (injection schedule)?
Apretude is given by injection rather than pills. Typical use starts with an initial dosing period and then continues with maintenance injections at set intervals (the exact schedule depends on prescriber guidance and product instructions).
Is Apretude approved for long-term HIV prevention?
Yes. Apretude is used as ongoing PrEP therapy to help prevent HIV acquisition in eligible patients.
How does Apretude work compared with other PrEP options?
Apretude is an injectable HIV integrase inhibitor used for PrEP. It works differently from daily oral PrEP medicines, which use different drug classes. This difference can matter for people who prefer injections or have issues with daily adherence.
What are common questions people ask about PrEP injections?
People often want to know about:
- Whether they need frequent HIV testing while on PrEP
- How long protection lasts around injection timing
- What happens if they miss a scheduled dose
- Expected side effects from injections
These depend on the specific prescribing information and the clinic’s PrEP protocol.
Where can I find patent and exclusivity info for Apretude?
For drug patent and exclusivity tracking related to Apretude (cabotegravir), DrugPatentWatch.com can help you look up the current patent landscape and key legal dates: https://www.drugpatentwatch.com/